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Abstract
Derangements of the prefrontal cortex (PFC) and of brainstem monoaminergic systems occur in de-
pression and schizophrenia. Anatomical and functional evidence supports a PFC control of the brainstem
monoaminergic systems. Similarly, the PFC contains a high density of monoamine receptors for which
antipsychotic drugs exhibit high aﬃnity. This raises the possibility that pathological or drug-induced
changes in PFC may subsequently alter monoaminergic activity. Recent data indicate that a substantial
proportion of PFC pyramidal neurons projecting to the ventral tegmental area (VTA) or the dorsal raphe
nucleus (DR) express the 5-HT2A receptor mRNA, which suggests that atypical antipsychotic drugs aﬀect
serotonergic and dopaminergic function by targeting PFC 5-HT2A receptors. Using electrophysiological
and tract-tracing techniques we examined whether PFC pyramidal neurons projecting to DR are segre-
gated from those projecting to the VTA. Sequential electrical stimulation of these nuclei in anaesthetized
rats evoked antidromic potentials from both areas in the same pyramidal neurons of the medial PFC (60%,
n=30). A similar percentage of dual DR+VTA projection neurons (50%) was obtained using the
reciprocal collision test (n=85). Similarly, tracer application (Fluoro-Gold in VTA and cholera toxin B
in DR, or vice versa) retrogradely labelled pyramidal neurons in PFC projecting to VTA (81¡18), to
DR (52¡9) and to both nuclei (31¡4, n=5 rats). Overall, these results indicate that the PFC may
simultaneously coordinate the activity of dopaminergic and serotonergic systems within a short temporal
domain, supporting a concerted modulation of the ascending serotonergic and dopaminergic activity
during antipsychotic drug treatment.
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Introduction
The prefrontal cortex (PFC) is involved in many higher
brain functions, including mnemonic processes,
attention and action planning, decision-taking, behav-
ioural inhibition and control of emotional signals
(Fuster, 2001 ; Miller & Cohen, 2001 ; Romo & Salinas,
2003). PFC functions largely rely on its extensive
and often reciprocal connectivity with a vast array
of cortical and subcortical structures (Fuster, 2001 ;
Groenewegen & Uylings, 2000; Miller & Cohen, 2001).
In particular, the medial PFC (mPFC) is reciprocally
connected with the dorsal raphe nucleus (DR), which
contains most ascending serotonergic (5-HT) neurons
(Aghajanian &Wang, 1977 ; Celada et al. 2001; Gabbott
et al. 2005; Hajo´s et al. 1998; Jankowski & Sesack, 2004 ;
Peyron et al. 1998; Sesack et al. 1989). A similar re-
ciprocal connectivity exists with the ventral tegmental
area (VTA), which contains mesocortical dopaminer-
gic (DA) neurons (Carr & Sesack, 2000 ; Gabbott et al.
2005; Geisler & Zahm, 2005; Thierry et al. 1979, 1983a ;
Tong et al. 1996b). Thus, aﬀerent excitatory pathways
from mPFC to these two nuclei exert a profound
inﬂuence on the activity of DA and 5-HT neurons
(Aghajanian & Wang, 1977 ; Celada et al. 2001; Hajo´s
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et al. 1998; Thierry et al. 1979, 1983a ; Tong et al. 1996b),
which in turn project to cortical and limbic areas, in-
cluding the PFC.
The PFC–DR–VTA connectivity is a particularly
interesting subject of study due to the involvement
of these brain areas in thought and aﬀective disorders.
Hence, the DA and 5-HT innervation of the PFC plays
important roles in cognitive processes, including
working memory and cognitive ﬂexibility (Clarke
et al. 2004; Robbins & Roberts, 2007 ; Williams &
Goldman-Rakic, 1995 ; Williams et al. 2002). Moreover,
alterations of the PFC have been reported in severe
psychiatric conditions such as depression and schizo-
phrenia which are also associated with derangements
of both monoaminergic systems (see for review
Benes & Berretta, 2001 ; Drevets, 2001 ; Harrison, 1999;
Lewis et al. 2005; Manji et al. 2001; Selemon &
Goldman-Rakic, 1999). Furthermore, the functional
interactions between the PFC, VTA, and DR may be
crucial for understanding the therapeutic action of
antidepressant and antipsychotic drugs, which target
transporters or receptors expressed by DA, 5-HT and
PFC neurons (Arnt & Skarsfeldt, 1998; Artigas et al.
1996; Bymaster et al. 1996; Corte´s et al. 1988; Mengod
et al. 1989; Santana et al. 2004, 2009 ; Weiner et al. 1991).
In particular, recent ﬁndings indicate the presence of
5-HT2A receptor mRNA in a large proportion of PFC
neurons projecting to the DR or VTA (Va´zquez-
Borsetti et al. 2008), which suggests that atypical anti-
psychotic drugs may partly exert their therapeutic
eﬀect by attenuating the activity of excitatory inputs to
these midbrain nuclei. Finally, high-frequency stimu-
lation of Brodmann area 25 (Cg25) in treatment-
resistant depressives induced an immediate clinical
improvement, an eﬀect that may involve the connec-
tivity of Cg25 with midbrain nuclei (Mayberg et al.
2005).
However, despite VTA-projecting and DR-
projecting pyramidal neurons in the PFC being
localized to the same areas (mainly prelimbic and in-
fralimbic subdivisions), it is unknown whether these
are segregated or overlapping populations. Using
electrophysiological and tract-tracing techniques, we
examined whether the PFC input to the VTA and the
DR arises from the same projection neurons, which
would raise the possibility of a concurrent PFC control
of the ascending DA and 5-HT pathways.
Experimental procedures
Animals
Male albino Wistar rats (Iﬀa Credo, France) weighing
250–300 g were used in this study. Animals were kept
in a controlled environment [12-h light/dark cycle
(lights on 07:00 hours) and 22¡2 xC room tempera-
ture] with food and water available ad libitum. All ex-
perimental procedures used in this study were in strict
compliance with the European Communities Council
directive 86/609/EEC on ‘Protection of Animals
Used in Experimental and Other Scientiﬁc Purposes’
of 24 November 1986 (O.J. of E.C. L358, 18/12/1986).
Electrophysiological recordings
We undertook two systematic studies to evaluate the
incidence of mPFC neurons simultaneously projecting
to the DR and the VTA. In the ﬁrst set of experiments,
we used the antidromic potential technique (Fuller &
Schlag, 1976) with sequential DR/VTA stimulation
while recording pyramidal neurons in mPFC. In a
second set of experiments, dual-projecting neurons
were identiﬁed using the reciprocal collision test
(Ferino et al. 1987; Shadow, 1982).
Surgery was performed as previously described
(Puig et al. 2003). Brieﬂy, rats were anaesthetized
(chloral hydrate, 400 mg/kg i.p.) and additional doses
of chloral hydrate (80 mg/kg, 1 ml/kg) were ad-
ministered i.v. Bipolar stimulating electrodes con-
sisted of two stainless-steel enamel-coated wires
(California Fine Wire, USA) with a diameter of 150 mm
and in-vitro impedances of 10–30 kV. Poles were
slightly separated under microscopic examination to
220–240 mm. Stimulating electrodes were stereo-
taxically implanted in both structures, the DR (AP
x7.6 tox7.8 ; Lx3.1 with 30x of inclination ; DVx6.2
to x6.8) and VTA (AP x5.6 to x6.0 ; L x0.5 ; DV
x8.2) Stereotaxic coordinates were taken from bregma
and according to the atlas of Paxinos & Watson (1986).
After implant, the electrodes were secured to the skull
with glue and dental cement. Constant current elec-
trical stimuli were generated with a Cibertec stimu-
lation unit CS-20 (Cibertec, Spain) connected to two
SIU 165 stimulus isolation units. The intensity of the
stimulating current (0.2 ms square pulses, 0.9 Hz) was
1.16¡0.08 mA for DR and 1.14¡0.07 mA for VTA in
the ﬁrst set of experiments, and 0.94¡0.03 mA for DR
and 0.98¡0.03 mA for VTA in the second set of ex-
periments (reciprocal collision test). Pyramidal neu-
rons were recorded with glass micropipettes ﬁlled
with 2 M NaCl. Typically, in-vitro impedance was be-
tween 4 and 10 MV. Single unit extracellular record-
ings were ampliﬁed with a Neurodata IR283 (Cygnus
Technology Inc., USA), post-ampliﬁed and ﬁltered
with a Cibertec ampliﬁer (Madrid, Spain) and com-
puted online using a DAT 1401plus interface system,
Spike2 software (Cambridge Electronic Design, UK).
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In the ﬁrst set of experiments we systematically
conﬁrmed that only a single pyramidal neuron was
recorded by identiﬁcation of antidromic activation
from the DR or the VTA (Fuller & Schlag, 1976). After
recording antidromically evoked spikes from one
of these sites (VTA or DR), the current was switched
to the other site (DR or VTA, respectively). Dual-
projection neurons were characterized by the presence
of antidromic spikes after stimulation of both sites.
In the second set of experiments dual-projecting
neurons were identiﬁed using the reciprocal collision
test. We measured the reciprocal collision time, de-
ﬁned as the maximal interval between stimulus ap-
plication at each site which produces a blockade of the
second evoked antidromic spike. With this technique,
it is assumed that one neuron projects to two struc-
tures when the reciprocal collision time is greater than
the diﬀerence between the latencies of the two anti-
dromic responses plus the refractory period of the
second axonal branch stimulated (Ferino et al. 1987;
Thierry et al. 1983b).
At the end of the experiments, rats were killed by an
overdose of anaesthetic. The placement of the stimu-
lating electrodes was veriﬁed histologically. The data
from rats with electrodes implanted outside the DR or
VTA were not used.
Tract-tracing studies
Animals were anaesthetized with sodium pentobarbi-
tal (60 mg/kg i.p.), and placed in a stereotaxic frame.
Glass capillary tubes were heated, pulled and the tips
broken to 30 mm outer diameter under microscopic
control. The micropipettes were ﬁlled with cholera
toxin B subunit (CTB, List Biological Laboratories,
USA) or Fluoro-GoldTM (FG; Fluorochrome LLC,
USA). A solution of CTB (2% in distilled water) was
iontophoretically injected into the DR (n=4) or the
VTA (n=1). The same animals subsequently received
iontophoretic injections of FG (2% in 0.1 M cacodylate
buﬀer ; pH 7.3) into the VTA (n=4) or the DR (n=1),
respectively. The injections were performed using
a 5-mA positive-pulsed direct current for a total of
5 min (7 s on/oﬀ for 10 min). After surgery, rats
were housed individually. Ten days later, the animals
were anaesthetized with an i.p. overdose of sodium
pentobarbital and perfused transcardially with 50 ml
calcium-free Tyrode’s solution (6.8 g/l NaCl, 0.4 g/l
KCl, 0.32 g/l MgCl2.6H2O, 0.10 g/l MgSO4.7H2O,
0.17 g/l NaH2PO4.H2O, 2.2 g/l NaHCO3, 1.1 g/l glu-
cose) containing 0.1% heparin at 37 xC, followed by
50 ml of warm (37 xC) and 300 ml of cold (4 xC)
ﬁxative (4% paraformaldehyde in 0.1 M phosphate
buﬀer ; pH 6.9). After perfusion, the skull was opened
and the brain carefully removed and stored for 2 d in
10% sucrose in 0.1 M phosphate-buﬀered saline (PBS)
(pH 7.4). The brains were then frozen by slow immer-
sion into dry-ice chilled isopentane. Tissue sections,
14-mm thick, were cut on a microtome-cryostat
(Microm HM500 OM, Germany), and mounted onto
Histogrip-treated glass slides (Zymed Laboratories
Inc., USA) and processed for the indirect immuno-
ﬂuorescence technique of Coons (1958). Thus, the
sections were preincubated in 0.1 M PBS for 15 min at
room temperature and then incubated for 3–4 d in a
humid chamber at 4 xC with a rabbit CTB antiserum
(1:1000; Sigma, USA) alone or in combination with
sheep tryptophan hydroxylase (TPH) antiserum
(1:100; Chemicon International, USA) or a tyrosine
hydroxylase (TH) monoclonal antibody (1 :1000 ; Dia-
sorin, USA) in 0.1 M PBS containing 0.3% Triton
X-100 and 2% BSA. Then the sections were rinsed
in 0.1 M PBS and incubated for 30 min at 37 xC in
the same buﬀer containing 0.3% Triton X-100 and ap-
propriate combinations of the following secondary
antibodies : Alexa Fluor1 546-goat anti-rabbit, Alexa
Fluor 4881-goat anti-mouse, Alexa Fluor1 488-
donkey anti-rabbit, AlexaFluor 5461-donkey anti-goat
(all 1 :500, Molecular Probes, The Netherlands) or
ﬂuorescein isothiocyanate (FITC)-donkey anti-sheep
(1 :50; Chemicon International). Finally, the sections
were washed in PBS and coverslipped using Mowiol
(Merck, Germany). The sections were observed in
an epiﬂuorescence microscope (Nikon Eclipse E1000,
Japan) and a confocal microscope equipped with a
spectral head (Leica SP2; Leica, Germany). In all in-
stances, FG was detected by its native ﬂuorescence.
Cell counting and data analysis
PFC sections processed for immunohistochemical de-
tection of CTB were analysed with the epiﬂuorescence
microscope to identify the distribution of pyramidal
neurons projecting to the VTA and/or the DR. The
medial and orbital cortices were then examined in
more detail with the confocal microscope. Ten con-
secutive optical sections (1 mm each) in the vertical axis
were scanned for the ﬂuorophores present in the tissue
(Alexa Fluor1 546 and FG) in adjacent frames all along
the medial and the orbital prefrontal cortices. The op-
tical sections were colourized (red for Alexa Fluor1
546 and green for FG) and merged with the confocal
microscope software. The red and green images were
combined to visualize double-labelled elements. Cell
counting was done on the red and green images sep-
arately using the Image J 1.32j software (by Wayne
Rasband, National Institute of Health, USA). The 10
optical sections were examined for each labelled
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element and cell proﬁles were considered positive
only when labelling was identiﬁed in more than six
consecutive planes.
Sections through the injection sites were observed
with the ﬂuorescence microscope and photographed
with a Nikon DXM1200 camera. The digital images
obtained were combined using the AnalySIS Software
(Soft Imaging System GmbH, Germany) to prepare
Figs 4 and 6. Images were treated with Adobe
Photoshop to adjust brightness, contrast and size to
make the ﬁnal ﬁgures.
Data are expressed as means¡S.E.M. Statistical
analyses were done using Student’s t test for in-
dependent data. Statistical signiﬁcance has been set at
the 95% conﬁdence level (two-tailed).
Results
Electrophysiological experiments
Two sets of electrophysiological experiments were
conducted, using the simple antidromic technique and
the reciprocal collision test, respectively. Figure 1
shows the recording and stimulation sites in the two
sets of experiments.
In the ﬁrst set (n=48 experiments), pyramidal neu-
rons in mPFC were identiﬁed by antidromic stimu-
lation from either the VTA or the DR. In 18 cases, the
histological examination revealed that one or other
electrodes were slightly misplaced. Therefore, data
were taken from 30 experiments performed in 10 dif-
ferent rats. Data on latencies and conduction velocities
correspond to the total number of experiments per-
formed, since these variables are not aﬀected by small
diﬀerences in electrode location.
Antidromic spikes were evoked in the same pyr-
amidal neuron by sequential stimulation of the DR
and VTA in 18/30 (60%) cases. Five neurons (16.7%)
were antidromically activated by DR (but not VTA)
stimulation whereas seven neurons (22.3%) were ac-
tivated by VTA (but not DR) stimulation. Figure 2
shows representative examples of the recording of a
pyramidal neuron projecting to the VTA, the DR and
both. The latencies of the antidromic spikes evoked by
(a)
(b) (c)
(d) (e)
Cg
PL
IL
OFC
Fig. 1. (a) Schematic drawing of a frontal section of the rat brain at AP+3.2 mm (Paxinos & Watson, CD edition, 1997,
with permission from Elsevier Science). The shaded area indicates the region where pyramidal neurons were recorded.
(b–e) Schematic representation of the location (black dots) of the tip of bipolar electrodes used to stimulate the ventral tegmental
area (b, d ) and the dorsal raphe nucleus (c, e). Panels (b) and (c) correspond to expt 1 (antidromic test) and panels (d ) and
(e) correspond to expt 2 (reciprocal collision test) (see text). Cg, Cingulate ; PL, prelimbic ; IL, infralimbic ; OFC, orbitofrontal
cortex.
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VTA stimulation were signiﬁcantly lower than those
evoked by DR stimulation (Table 1).
In a second set of experiments, using the reciprocal
collision test, a total of 85 neurons were antidromically
activated from either the DR or VTA. Of these, 20 were
only activated from DR, 23 only from VTA and 42
from both nuclei (23%, 27%, 50%, respectively) (Fig. 3).
Table 1 shows the latencies of antidromic spikes ob-
tained with the reciprocal collision test.
Tract-tracing studies
In order to examine for the presence of PFC pyramidal
neurons with simultaneous projections to the DR
and the VTA, we conducted a series of tract-tracing
experiments in which CTB and FG were micro-
iontophoretically applied in the DR and VTA, re-
spectively (n=4 rats). We also examined one animal
where the two tracers were switched (CTB in the VTA
and FG in the DR) to examine whether this provided
comparable results.
Figure 4 shows ﬂuorescence microscope images
depicting the localization of the tracers in the DR
(CTB) and the VTA (FG) as well as the schematic rep-
resentation of the localization of pyramidal neurons in
PFC projecting to one or both nuclei (n=4). In these
rats, the tracers were conﬁned within the respective
nuclei, as shown by the co-localization of the tracer
and the markers of 5-HT neurons of the DR (TPH) and
DA neurons of the VTA (TH).
CTB application in the DR labelled a large number
of neurons in layer V of the prelimbic and infralimbic
subdivisions of the mPFC (Fig. 4) as well as a more
moderate number of neurons in the anterior cingulate
as well as in lateral and ventral orbitofrontal cortex.
Labelled neurons were found in both hemispheres.
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Fig. 2. Identiﬁcation of pyramidal neurons in the medial prefrontal cortex (mPFC) by antidromic activation from the dorsal raphe
nucleus (DR) and ventral tegmental area (VTA). Upper panels are raster plots. In these, ordinates are in ms and represent the
time at which an antidromic potential (each dot) is recorded in a PFC pyramidal neuron when stimulating the DR or VTA
(stimulation times are shown by black bars). Dots at t=0 correspond to the stimulus artifact (shown with a black arrow). The
neurons in panels (a–c) project to the VTA, DR and VTA+DR, respectively, as shown by the existence of antidromic potentials
(dots) at a ﬁxed latency from the stimulus when the respective nuclei are stimulated. Lower panels : actual spike traces
corresponding to the time periods indicated in raster plots, immediately before and after switching the stimulating current
from the DR to the VTA electrode. Asterisks denote antidromic spikes missing due to collisions with ongoing spontaneous
action potentials during stimulation of the DR or VTA. Grey arrows indicate the stimulus artifact. (a) Example of a mPFC
pyramidal neuron showing antidromic potentials after stimulation from the VTA (latency 4.4 ms) but not from DR.
(b) Example of a mPFC pyramidal neuron showing antidromic potentials after stimulation from the DR (latency 15 ms) but
not from the VTA. (c) Example of a mPFC pyramidal neuron showing antidromic potentials after stimulation from the DR
(latency 15.8 ms) and from the VTA (latency 11.6 ms).
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A few neurons were labelled in the agranular insular
cortex, adjacent to those in the orbitofrontal cortex.
FG application into the VTA also labelled a large
number of neurons in the prelimbic and infralimbic
mPFC (Fig. 4). With the exception of the orbitofrontal
cortex, which contained only a few FG-labelled
neurons, the localization of VTA-projecting neurons
was very similar to that of neurons projecting to
the DR, in the cingulate, prelimbic and infralimbic
subdivisions. In contrast to injections in the DR, FG
application in the VTA mostly labelled neurons in
the ipsilateral hemisphere, and, only a few VTA-
projecting neurons were found in the contralateral
side. Figure 5 shows the actual localization of mPFC
pyramidal neurons projecting to DR (Fig. 5a), VTA
(Fig. 5b) or both (Fig. 5b).
Figure 6 shows ﬂuorescence microscope images
depicting the localization of the tracers in the DR and
VTA of the rat injected with the inverse tracer combi-
nation (e.g. FG in the DR and CTB in VTA). This re-
sulted in a distribution of labelled neurons similar to
that described above. A large number of FG-labelled
neurons (DR-projecting) were found in the medial and
orbitofrontal cortex of both hemispheres. Similarly,
CTB application in the VTA labelled a large number of
neurons in the ipsilateral mPFC and no neurons in the
orbitofrontal cortex. Very few CTB-labelled cells were
detected in the contralateral mPFC. Table 2 shows the
absolute number of DR-projecting and VTA-projecting
neurons in the ipsilateral PFC of the ﬁve rats ex-
amined. On average, the percentage of dual-projection
neurons was 63¡6% for those projecting to DR and
42¡6% for those projecting to VTA.
Discussion
The present study presents electrophysiological and
histological evidence supporting the existence of a
substantial population of mPFC pyramidal neurons
that simultaneously project to the VTA and DR.
The proportion of dual-projection neurons can be
estimated to be 50–60% according to the electro-
physiological experiments. This was conﬁrmed by the
results from histological experiments, which also re-
vealed the existence of a considerable population of
mPFC neurons projecting to the DR and VTA. Thus,
the present results indicate that the ascending 5-HT
and DA pathways are under a concurrent control
of their activity by the same pyramidal neurons in
the mPFC.
Methodological considerations
In agreement with pilot observations (Puig et al. 2003),
the use of the antidromic activation/collision test
technique enabled a systematic identiﬁcation of PFC
pyramidal neurons projecting simultaneously to the
DR and VTA. A similar proportion was obtained using
the reciprocal collision test (Ferino et al. 1987; Shadow,
1982; Thierry et al. 1983a), which uses more stringent
experimental conditions to avoid the misidentiﬁcation
of previously silent projection neurons recorded
extracellularly that might be activated by antidromic
spikes. This technique was used to identify the exist-
ence of eﬀerent neuronal projections with branching
axons in diﬀerent structures, including the PFC. In a
pioneering study, Thierry et al. (1983a) reported on
diﬀerent patterns of dual-projection neurons in mPFC
innervating several structures such as mediodorsal
thalamus, VTA, substantia nigra, superior colliculus,
central grey and habenula. The present study is in ac-
cord with the view that PFC pyramidal neurons have
branching axons to simultaneously coordinate the ac-
tivity of various subcortical structures. The latencies
found herein for single and dual-projection neurons
do not diﬀer and are within the range of those pre-
viously reported for mPFC pyramidal neurons pro-
jecting to the 5-HT and DA nuclei (Celada et al. 2001;
Peterson et al. 1990; Puig et al. 2003; Thierry et al.
1983a).
Table 1. Latencies of antidromic spikes evoked in medial
prefrontal cortex (mPFC) pyramidal neurons by stimulation
of midbrain monoaminergic nuclei
Stimulation site Latency (ms)
Expt 1 (antidromic activation)
DR (n=31) 13.7¡0.8
VTA (n=35) 7.9¡0.7*
Expt 2 (reciprocal collision test)
All neurons
DR (n=61) 12.6¡0.5
VTA (n=65) 7.6¡0.7*
Dual-projection neurons
DR (n=42) 12.1¡0.6
VTA (n=42) 7.5¡0.7*
DR; Dorsal raphe nucleus ; VTA, ventral tegmental area.
Data (mean¡S.E.M.) are latencies of antidromic spikes
reaching layer V mPFC neurons by stimulation of bipolar
electrodes located in the DR and VTA (see Fig. 1).
The intensity of the stimulating current (0.2 ms square
pulses, 0.9 Hz) was 1.16¡0.08 mA for DR and 1.14¡0.07 mA
for VTA in the ﬁrst set of experiments, and 0.94¡0.03 mA
for DR and 0.98¡0.03 mA for VTA in the second set of
experiments (reciprocal collision test).
* p<0.0002 vs. DR, Student’s t test.
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A signiﬁcantly lower latency was found for the
PFC–VTA pathway than for the PFC–DR pathway,
which may be due to the shorter distance between
mPFC and VTA and the proximity of the latter nucleus
to the median forebrain bundle (MFB), implying that
fast-conduction myelinized axons exist for most of the
trajectory between the mPFC and VTA.
The use of the tract-tracing techniques provided
essentially the same results as electrophysiological
techniques, indicating that a substantial proportion of
PFC neurons project simultaneously to the DR and
VTA. Pyramidal neurons projecting to the DR and/or
VTA were mainly found in layer V of the infralimbic,
prelimbic and cingulate cortices, in accord with pre-
vious reports in the literature using either electro-
physiological or tract-tracing techniques (Aghajanian
& Wang, 1977 ; Celada et al. 2001; Gabbott et al. 2005;
Geisler & Zahm, 2005; Hajo´s et al. 1998; Jankowski
& Sesack, 2004 ; Peyron et al. 1998; Sesack et al. 1989;
Thierry et al. 1979, 1983b ; Tong et al. 1996b, 1998).
Similarly, more DR- than VTA-projecting neurons
were found in the orbitofrontal cortex, which is in
accord with previously reported data (Gabbott et al.
2005; Geisler & Zahm, 2005; Peyron et al. 1998).
The technique of microiontophoretic application
allows a restricted application of the tracers (see e.g.
Va´zquez-Borsetti et al. 2008, using the same method-
ology as the present study). One possible limitation of
the use of FG and CTB is their uptake by damaged
ﬁbres of passage close to the application site. CTB has
been reported to be taken up by ﬁbres of passage
(Chen & Aston-Jones, 1995). Most studies using FG
have reported no uptake (Pieribone & Aston-Jones,
1988 ; Schmued & Fallon, 1986 ; Schmued & Heimer,
1990), whereas one study found FG uptake after
pressure injection (Dado et al. 1990). This potential
(a) (b) (c)
st. DR + VTA st. VTA + DR st. DR + VTA
R V V VR R
V R VRR V
R V R*
R R RV VV
* *
DR
VTA
10 ms
Fig. 3. Identiﬁcation of pyramidal neurons in medial prefrontal cortex projecting to dorsal raphe nucleus (DR) and ventral
tegmental area (VTA) by antidromic activation from these areas and reciprocal collision test. (a) Diagram of the stimulating
and recording sites. (b) Example of a pyramidal neuron showing antidromic potentials after stimulation from DR (shown
by R; latency 15.4 ms) and from VTA (shown by V; latency 8.2 ms). The asterisk denotes a missing antidromic spike when
the distance between two consecutive stimulus was 21 ms (collision test). This neuron, when stimulated from VTA had a
refractory period of 2 ms. (c) Left panel : example of reciprocal collision test showing a neuron antidromically activated from
VTA (latency 9.1 ms) and DR (latency 14.4 ms). The refractory period when stimulated from DR was 2.2 ms. The asterisk
denotes a missing antidromic spike when the distance between consecutive stimuli was 9 ms (collision test). Right panel :
the reversal in the order of stimulation also induced a blockade of the second antidromic spike in the same neuron.
Stimulus artifacts induced after DR or VTA stimulations are shown with a black or grey arrow, respectively.
PFC projections to monoaminergic nuclei 295
limitation is minimized by the microiontophoretic ap-
plication of the tracer, as used in the present study.
This procedure resulted in a tracer distribution within
the boundaries of the DR and VTA as observed by the
coincidence of the tracer with TPH and TH immuno-
reactivity. Moreover, tracer uptake by damaged MFB
VTA DR VTA DR
VTA DR VTA DR
Rat 1 Rat 2
c i c i
Rat 3 Rat 4
c i c i
Fig. 4. Retrograde labelling of prefrontal cortex (PFC) neurons after microiontophoretic application of Fluoro-Gold (FG) in the
ventral tegmental area (VTA) and cholera toxin B subunit (CTB) in the dorsal raphe nucleus (DR). For each rat (nos. 1–4),
schematic representations of coronal sections at the PFC level (+3.2 mm from bregma; Paxinos & Watson, 1986) illustrate the
distribution of cells retrogradely labelled with FG (light blue dots), CTB (orange dots) or both tracers (black dots). Every dot
represents ﬁve labelled neurons. Note the presence of numerous neurons projecting to the VTA in the prelimbic and infralimbic
cortices, extending dorsally to the cingulate and secondary motor areas and ventrally to the dorsal peduncular and orbital
cortices in the hemisphere ipsilateral (i) to the injection site. Only a few VTA-projecting neurons are found in the prelimbic
cortex of the contralateral (c) side. Neurons projecting to the DR are detected in both the ipsilateral and contralateral
hemispheres, mainly concentrated in the prelimbic and insular agranular cortices. CTB-labelled cells are also be encountered
in the orbital, infralimbic and cingulate cortical areas. The location of injection sites in each rat is illustrated in the
corresponding photomicrographs obtained from sections through the brainstem which show tyrosine hydroxylase
immunoreactivity (green) and FG ﬂuorescence (white) in the VTA and tryptophan hydroxylase immunoreactivity (green)
and CTB immunoreactivity (red) the DR. Images were obtained with a Colorview camera in a Nikon Eclipse ﬂuorescence
microscope and were overlapped using AnalySIS software. Bar, 200 mm.
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ﬁbres after application in the VTA would have re-
sulted in a more widespread distribution of labelled
neurons in the PFC, particularly in the primary
and secondary motor areas, that contain the largest
proportion of corticospinal ﬁbres of all PFC subdiv-
isions (Gabbott et al. 2005). Only one rat (rat no. 3 ; see
Fig. 3) contained some labelled neurons in the sec-
ondary motor area labelled by the tracer application
in the VTA. Yet in this case, the number of labelled
neurons was higher in the mPFC (cingulate, prelimbic,
infralimbic) than in the motor PFC.
Moreover, the ratio between the number of VTA-
projecting neurons and DR-projecting neurons in
(a) (b) (c)
(d) (e) (f )
Fig. 5. Confocal photomicrographs of a prefrontal cortex
(PFC) coronal section of a rat (no. 4 ; see Fig. 3) that received
cholera toxin B subunit (CTB) in the dorsal raphe nucleus
(DR) and Fluoro-Gold (FG) in the ventral tegmental area
(VTA), after incubation with CTB antiserum. FG was
visualized by its own ﬂorescence. The images in panels
(a–c) are montages of 10 consecutive optical sections (1 mm
each) colourized and merged with the confocal software.
Panels (d–f ) show enlargements of the boxed area in panel
(c). (a, d ) CTB-immunoreactive cell bodies are observed
along layer V of the mPFC. (b, e) FG ﬂuorescence shown
in green is also present in numerous cells in layer V.
(c, f ) Superimposed images show the presence of CTB (red),
FG (green) or both tracers (yellow). Black arrows on the
right mark the limit between the cingulate and the
prelimbic cortices (upper arrow) and the limit between
the prelimbic and infralimbic cortices (lower arrow). Bar,
200 mm.
c i
VTR DR
Fig. 6. Retrograde labelling of prefrontal cortex neurons after
microiontophoretic application of cholera toxin B subunit
(CTB) in the ventral tegmental area (VTA) and Fluoro-Gold
(FG) in the dorsal raphe nucleus (DR). Schematic
representation of a coronal section at the prefrontal cortex
level (+3.2 mm from bregma; Paxinos & Watson, 1986)
illustrating the distribution of cells retrogradely labelled
with FG (blue dots), CTB (orange dots) or both tracers
(violet dots) in rat no. 5. Every dot represents ﬁve labelled
neurons. The distribution of VTA- and DR-projecting cells
is comparable to that described in Fig. 3. The location of
injection sites is illustrated in photomicrographs obtained
from sections through the brainstem of the same rat which
show tyrosine hydroxylase immunoreactivity (green) and
CTB immunoreactivity (red) in the VTA and tryptophan
hydroxylase immunoreactivity (green) and FG ﬂuorescence
(white) in the DR. Images were obtained with a Colorview
camera in a Nikon Eclipse ﬂuorescence microscope and
were overlapped using AnalySIS software. Bar, 200 mm.
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the mPFC was 1.5 on average (Table 2), which is in
close agreement with that reported using single
applications of wheat germ agglutinin conjugated
with horseradish peroxidase in each site (VTA/DR
ratios of 3.28, 1.21 and 1.02 for the infralimbic, pre-
limbic and cingulate cortices, respectively ; see table 3
in Gabbott et al. 2005). Based on this evidence, it
is most likely that the present methods speciﬁcally
labelled pyramidal neurons in mPFC projecting to the
DR and VTA.
Notwithstanding the reliability of the two techni-
ques used in the present study, a quantitative dif-
ference was noted. The percentage of dual-projection
neurons obtained with the antidromic activation tech-
nique was 50–60% which was very similar (63%) to
that obtained by tract-tracing techniques when results
were expressed by reference to the total of DR-
projecting neurons. A lower proportion (42%) was
obtained when expressing the data by reference to
VTA-projecting neurons, which are more abundant
in mPFC. One possible reason for this diﬀerence is the
smaller size of the VTA compared to the DR, which
extendsy2 mm along the rostrocaudal axis. Here it is
possible that only a small proportion of the actual
number of PFC neurons projecting to the DR had been
labelled by tracer application in this nucleus compared
with those labelled by tracer application in the VTA.
This would result in an apparently greater number
of VTA-projecting neurons in the mPFC, as observed,
and therefore result in a comparatively lower per-
centage of dual-projection neurons when expressed by
reference to VTA. Moreover, it may be that electrical
stimulation activates myelinized axons in the VTA
that would not take up the tracers.
Functional and therapeutic implications
Several previous studies have examined the collater-
alization of PFC axons innervating subcortical struc-
tures (Cassell et al. 1989; Ferino et al. 1987; Gabbott
et al. 2005; Pinto & Sesack, 2000 ; Thierry et al. 1983a)
with varying results. Some studies have reported
little collateralization of cortico-accumbens neurons
(Pinto & Sesack, 2000), whereas others have found a
signiﬁcant branching of PFC axons innervating the
contralateral PFC and several subcortical structures
(Cassell et al. 1989; Ferino et al. 1987; Thierry et al.
1983a).
The results of the present study closely match those
of the original study by Thierry et al. (1983a), who
reported a very high proportion of branched axons
of neurons projecting to the VTA (ventromedial teg-
mentum, as designated in the 1980s) and substantia
nigra compacta. Overall, this indicates that a sub-
population of PFC neurons projecting to the brainstem
show extensive collateralization, which would allow
for the synchronization of the activity of several mid-
brain nuclei following PFC activation.
The mPFC also exerts a very important control of
the activity of 5-HT neurons. Two independent studies
revealed that more than 80% of DR 5-HT neurons re-
sponded to the electrical stimulation of the mPFC
(Celada et al. 2001; Hajo´s et al. 1998). The responses
elicited diﬀer, possibly depending on the stimulation
site. Stimulation of the infralimbic PFC resulted in a
Table 2. Labelling of medial prefrontal cortex neurons by tracer application
(CTB or FG) in the DR and VTA
VTA DR Both
Rat no. 1 49 22 15 (31%, 68%)
Rat no. 2 147 47 38 (26%, 81%)
Rat no. 3 88 75 39 (44%, 52%)
Rat no. 4 57 50 33 (58%, 66%)
Rat no. 5 (FG in VTA; CTB in DR) 65 68 32 (49%, 47%)
Average 81¡18 52¡9 31¡4 (42%, 63%)
CTB, Cholera toxin B subunit ; FG, Fluoro-Gold ; DR, dorsal raphe nucleus ; VTA,
ventral tegmental area.
Data are numbers of neurons labelled by CTB application in the VTA and FG
application in the DR (rat nos. 1–4) or vice versa (rat no. 5) in individual sections of
the PFC (approx. bregma+3.2 ; Paxinos & Watson, 1986).
Values in parentheses are the percentages of double-labelled neurons projecting to
VTA and DR, respectively.
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majority of inhibitory responses in 5-HT neurons,
which were not blocked by the selective 5-HT1A re-
ceptor antagonist WAY-100635, while stimulation at
a more dorsal site increased the proportion of excit-
atory responses (Hajo´s et al. 1998). However, another
study, reported that mPFC stimulation evoked both
5-HT1A and GABAA receptor-dependent inhibitions
and AMPA and NMDA receptor-dependent excita-
tions of 5-HT neurons (Celada et al. 2001). Subsequent
tracing studies revealed that ventral aspects of the PFC
mainly synapse on GABA cells in the DR (Jankowski &
Sesack, 2004 ; Varga et al. 2001), and establish a low
proportion of synaptic contacts with 5-HT cells
(Jankowski & Sesack, 2004).
Thus, both electrophysiological and track-tracing
studies indicate that the PFC may modulate 5-HT
neuron activity via direct excitatory inputs as well
as indirect inhibitory inputs involving GABAA and
5-HT1A receptors. However, the electrical and chemi-
cal stimulation of the mPFC increased the activity
of DR 5-HT neurons and increased DR 5-HT re-
lease (Amargos-Bosch et al. 2003; Celada et al.
2001; Martin-Ruiz et al. 2001) supporting the exist-
ence of overall excitatory PFC input onto DR 5-HT
neurons.
Similarly, the PFC provides an important aﬀerent
excitatory pathway to the VTA, as reported by ana-
tomical and electrophysiological studies (Carr &
Sesack, 2000 ; Gabbott et al. 2005; Geisler & Zahm,
2005; Hurley et al. 1991; Sesack & Pickel, 1992 ; Thierry
et al. 1979, 1983b ; Tong et al. 1996a, 1998). mPFC af-
ferents synapse onto DA and non-DA (GABA) cells
with well established connectivity patterns. Thus, DA
neurons projecting back to PFC and to other un-
identiﬁed structures (but not to nucleus accumbens)
receive monosynaptic inputs from PFC (Carr &
Sesack, 2000). Similarly, VTA GABAergic neurons
projecting to nucleus accumbens are innervated by
direct mPFC inputs (Carr & Sesack, 2000). In this
manner, mPFC aﬀerents can regulate the activity of
the mesocortical DA pathway and the mesolimbic
GABAergic pathway, in addition to DA and GABA
cells projecting to other structures by monosynaptic
excitatory inputs (Carr & Sesack, 2000). In-vitro re-
cordings in the VTA indicate that these excitatory in-
puts are important to elicit long-term changes in the
activity of DA and GABA cells (Bonci & Malenka,
1999). In-vivo recordings indicate that PFC inputs
are critical to evoke burst ﬁring in DA cells (Gariano &
Groves, 1988 ; Overton & Clark, 1997) yet this may
involve both direct and indirect pathways (i.e. via
laterodorsal/pedunculopontine tegmentum) (Grace
et al. 2007).
The present data may have several important
pathophysiological and pharmacological implications.
The ascending DA and 5-HT systems have been
implicated in emotional control, in close relationship
with other structures (PFC, cingulate cortex, hippo-
campus, amygdala, etc.) making up the extended
limbic system (Morgane et al. 2005). Dopamine
neurons increase their activity to signal rewards or
reward-associated stimuli (Schultz, 2004, 2007) and
increases in DR activity have also been reported in
response to future rewards (Tanaka et al. 2004). On the
other hand, both systems are involved in cognitive
processes. Among other functions, dopamine and
serotonin play a role in the maintenance of persistent
neuronal activity in dorsolateral PFC during working-
memory tasks (Williams & Goldman-Rakic, 1995 ;
Williams et al. 2002).
Based on the present results, we suggest that
relevant behavioural or emotional stimuli reaching
the PFC may evoke concerted changes of the activity
of the ascending DA and 5-HT neurons. This simul-
taneous control would occur within a very short
temporal domain (typically <20 ms) and would con-
currently set the DA and 5-HT tone in various sub-
cortical and cortical areas (including the PFC). These
phasic PFC inputs would add to the tonic regulation
of 5-HT and DA activity which is strongly dependent
on inputs from locus coeruleus (via a1-adrenoceptor
activation ; VanderMaelen & Aghajanian, 1983) and
hippocampus (via nucleus accumbens–ventral palli-
dum inputs) (Grace et al. 2007), respectively.
Similarly, the present observations may have some
implications for the pathophysiology and treatment of
severe psychiatric disorders such as depression and
schizophrenia. Persistent changes in the metabolic ac-
tivity of the PFC in these disorders have been reported
(Andreasen et al. 1997; Catafau et al. 1994; Ressler &
Mayberg, 2007 ; Shergill et al. 2000). These alterations
may translate into a malfunction of 5-HT and DA
systems perhaps underlying depressive and psychotic
symptoms. Moreover, drugs acting on receptors/
transporters highly expressed in the PFC such as an-
tidepressant or atypical antipsychotic drugs may in-
directly modulate the 5-HT and DA activity via actions
on PFC targets (Bortolozzi et al. 2003; Diaz-Mataix et al.
2005). In particular, atypical antipsychotic drugs have
high in-vitro aﬃnity for 5-HT2A receptors (Arnt &
Skarsfeldt, 1998 ; Bymaster et al. 1996) and produce a
large occupancy of cortical 5-HT2 receptors at thera-
peutic dosage (Kapur et al. 1999). The present results,
together with our previous observations on the pres-
ence of 5-HT2A receptor mRNA in y55–60% of PFC
neurons projecting to the DR or VTA, suggest that
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atypical antipsychotic drugs may modulate the ac-
tivity of DA and 5-HT neurons in a synchronous and
coordinated way, an eﬀect possibly involved in their
therapeutic activity in schizophrenia and as enhancers
of the antidepressant activity of SSRIs (Zhang et al.
2000). Moreover, atypical antipsychotic drugs also
display moderate-high aﬃnity for other mono-
aminergic receptors expressed in mPFC (Pieribone
et al. 1994; Pompeiano et al. 1992, 1994 ; Santana et al.
2004, 2009). Although further studies are required to
examine whether these receptors are also expressed in
pyramidal neurons projecting to VTA/DR, these ob-
servations support the view that atypical antipsychotic
drugs may partly exert their therapeutic action by
distally regulating – among others – the activity of as-
cending monoaminergic neurons.
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